Skip to content

Clinical trials

Hereditary Sensory and Autonomic Neuropathies trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hereditary Sensory and Autonomic Neuropathies Country / region: China Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20161
20171
20183
20201
20211
20223
20231
20241
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Unknown status5
Recruiting4
Terminated4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jinling Hospital, China2
Peking Union Medical College Hospital2
The Third Affiliated hospital of Zhejiang Chinese Medical University2
BeiGene1
Chipscreen Biosciences, Ltd.1
Convalife (Shanghai) Co., Ltd.1
EMD Serono Research & Development Institute, Inc.1
Ensem Therapeutics1
Fudan University1
Haihe Biopharma Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hereditary Sensory and Autonomic Neuropathies18
Ischemic Stroke3
Breast Neoplasms2
Convalescence2
Endometrial Neoplasms2
Ovarian Neoplasms2
Recurrence2
Arthritis, Rheumatoid1
Brain Injuries, Traumatic1
Breast Diseases1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.